Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
PaperCitations, authors & open-access status
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,106 citations, 1996 year and closed oa status.
2,106
Citations
1996
Year
closed
OA Status